- News & Analysis
- Home
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Publications
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- Video
- Subscribe
- Newsletters
- Events
Page 32
RecargaPay tops up series C to $80m
The mobile payment app developer has expanded an Experian-backed round with a $10m extension, taking its total funding to approximately $110m.
Nov 2, 2021Cover builds out $60m series B
Existing investor Lennar returned to back the modular homebuilder in a round led by Gigafund, bringing its overall funding to over $71m.
Nov 2, 2021Aculys Pharma accepts SoftBank-led round
SoftBank’s Vision Fund 2 led a $59.7m round which will support Aculys in bringing a sleep disorder medication it has licensed to Japan.
Nov 2, 2021Daily Deal Round Up: November 1, 2021
Cell therapy developer Hopstem completed a $40m Eli Lilly-backed series B round while cybersecurity technology developer SlashNext secured $26m from investors including Telia and Ayala Group.
Nov 1, 2021Infinium gets $69m funding influx
The electofuel provider's latest round was co-led by NextEra Energy Resources and Amazon Climate Pledge Fund and included Mitsubishi Heavy Industries.
Nov 1, 2021Daily Deal Round Up: October 29, 2021
Wells Fargo Strategic Capital took part in a $52.5m round for digital mortgage platform developer Maxwell while corporate-backed music distributor UnitedMasters closed a $50m series C.
Oct 29, 2021Daily Deal Round Up: October 28, 2021
Cybersecurity software developer Sonrai Security, small business insurance provider Coterie and fashion brand Love, Bonito each raised $50m in corporate-backed rounds.
Oct 28, 2021Crossbeam shines with $76m series C
Salesforce Ventures, Slack Fund, HubSpot Ventures and Okta Ventures all returned to back the commercial partnership platform developer.
Oct 28, 2021Pipefy lets through $75m
SoftBank Latin American Fund was the largest investor in a round bringing the workflow software provider’s funding to approximately $139m to date.
Oct 28, 2021Juventas receives $63m injection
The Casi Pharmaceuticals-backed immunotherapy developer has completed a $63m series C round co-led by CICC and Oceanpine Capital.
Oct 28, 2021
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.